secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001213900-25-030353
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aditxt invests $1.5M in Evofem via convertible note and warrant as part of merger extension
--------------------------------------------------------------------------------

- Aditxt purchased a $2,307,692 senior subordinated convertible note of Evofem and a warrant for 149,850,150 shares of Evofem common stock for $1,500,000.
- $750,000 of the purchase price was funded on April 8, 2025; remaining $750,000 due by April 16, 2025 under a waiver agreement.
- Note bears 8% interest (12% on default), matures April 8, 2028, convertible at $0.0154 per share; warrant exercise price also $0.0154, five-year term.
- Evofem waived its termination right under the merger agreement until April 16, 2025; end date extended to September 30, 2025.
- Transaction is part of Amendment No. 5 to the Amended and Restated Merger Agreement between Aditxt, Adifem, and Evofem.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390025030353/0001213900-25-030353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390025030353/ea0237743-8k_aditxt.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-030353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer